TD Asset Management Inc Sells 13,830 Shares of Kestra Medical Technologies, Ltd. $KMTS

TD Asset Management Inc trimmed its holdings in shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) by 14.9% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 78,718 shares of the company’s stock after selling 13,830 shares during the period. TD Asset Management Inc’s holdings in Kestra Medical Technologies were worth $1,305,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Quarry LP purchased a new stake in Kestra Medical Technologies during the 1st quarter valued at about $33,000. Virtu Financial LLC purchased a new stake in Kestra Medical Technologies during the 1st quarter valued at about $210,000. Armistice Capital LLC purchased a new stake in Kestra Medical Technologies during the 1st quarter valued at about $312,000. Zimmer Partners LP purchased a new stake in Kestra Medical Technologies during the 1st quarter valued at about $374,000. Finally, Russell Investments Group Ltd. purchased a new stake in Kestra Medical Technologies during the 1st quarter valued at about $457,000.

Analyst Upgrades and Downgrades

KMTS has been the topic of several research analyst reports. Wells Fargo & Company dropped their price target on Kestra Medical Technologies from $28.00 to $27.00 and set an “overweight” rating on the stock in a research note on Thursday, July 17th. Wall Street Zen downgraded Kestra Medical Technologies from a “hold” rating to a “sell” rating in a research note on Sunday, September 28th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Kestra Medical Technologies in a research note on Wednesday, October 8th. Five equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $27.33.

Kestra Medical Technologies Trading Down 1.2%

Shares of KMTS opened at $26.07 on Thursday. Kestra Medical Technologies, Ltd. has a 52 week low of $13.25 and a 52 week high of $27.71. The company has a debt-to-equity ratio of 0.23, a quick ratio of 6.84 and a current ratio of 6.84. The stock’s 50-day moving average price is $21.20 and its 200-day moving average price is $20.19.

Kestra Medical Technologies (NASDAQ:KMTS) last released its quarterly earnings results on Thursday, September 11th. The company reported ($0.46) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.66) by $0.20. The business had revenue of $19.37 million during the quarter, compared to analyst estimates of $17.68 million. Kestra Medical Technologies has set its FY 2026 guidance at EPS.

Kestra Medical Technologies Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.